Can you renew a patent? No.
Not by paying more, not by refiling, not by petition. A patent runs its term and then the invention is public permanently.
Maintenance fees are not renewal fees, despite the name used in many countries. They keep a patent alive within its term; they add nothing to it.
The confusion is understandable and it costs people money, because it leads owners to defer decisions on the assumption that more time can be bought.
What can and cannot be done
| Possible? | |
|---|---|
| Renew or extend the term | No |
| Keep a patent alive within its term | Yes — maintenance fees |
| Recover days lost to USPTO delay | Yes — PTA, calculated at grant |
| Recover time lost to FDA review | Yes — PTE, up to 5 years |
| Revive after a missed fee | Sometimes, by petition |
| Revive after term expiry | Never |
| Refile the same invention | No — your own patent is prior art |
| Patent a genuine improvement | Yes — new term, improvement only |
Maintenance fees keep, they do not extend
| Fee | Due after grant | Large | Small (40%) | Micro (20%) |
|---|---|---|---|---|
| First | 3.5 years | $2,150 | $860 | $430 |
| Second | 7.5 years | $4,040 | $1,616 | $808 |
| Third | 11.5 years | $8,280 | $3,312 | $1,656 |
| Total | $14,470 | $5,788 | $2,894 |
Paying all three gets you to the twenty-year mark. Nothing beyond it.
Missing one ends the patent early. So the fees are a floor on losing time, not a mechanism for gaining it.
Each has a six-month grace period with a surcharge, after which the patent expires permanently and without notice. See patent maintenance fees.
The two real extension mechanisms
| Patent Term Adjustment | Patent Term Extension | |
|---|---|---|
| Compensates for | USPTO delay in examination | FDA regulatory review |
| Applies to | Any utility patent | Regulated products |
| Calculated | At grant, automatically | On application |
| Maximum | Days lost, less applicant delay | 5 years |
| Cap | — | 14 years remaining from approval |
| Patents per product | — | One |
| Deadline | — | 60 days from FDA approval |
| Requestable later | No | No |
Neither is available on request when a patent is running out. PTA is computed at grant; PTE must be applied for within sixty days of approval.
Both are corrections for delay, not rewards for value. See patent term extension.
Terminal disclaimers go the other way
| Effect | Caps the term to an earlier related patent |
| Filed | To overcome double patenting |
| Reversible | No |
| Common in | Families with several related patents |
A terminal disclaimer shortens a patent. Where one was filed, the capped date governs regardless of any adjustment earned.
Why refiling does not work
| Attempt | Result |
|---|---|
| File the same invention again | Rejected — your own patent is prior art |
| File a continuation | Expires with the parent |
| File a CIP | New matter gets a new date; old matter keeps the old one |
| Patent a genuine improvement | New term, covering the improvement only |
Continuations add coverage, never term. A continuation filed in 2024 from a 2016 parent expires in 2036.
Improvement patents are the legitimate version of the idea. A real improvement gets its own twenty years covering that improvement, while the original invention still becomes public on schedule.
That is not extension. Competitors are free to practise the original once it expires; they simply cannot use the improvement. See patent family.
Why the confusion is so common
| Source of confusion | Reality |
|---|---|
| "Renewal fees" abroad | Keep a patent alive; do not extend |
| Trademarks genuinely renew | Indefinitely — patents never |
| Copyright terms were once extended | By legislation, not by owners |
| Domain names renew | Different system entirely |
| "Maintenance" sounds ongoing | It ends at 11.5 years |
Trademarks are what people are thinking of. They renew indefinitely so long as the mark is used, which is genuinely perpetual protection on the brand.
Patents were designed to expire. The bargain is disclosure now in exchange for a limited monopoly, and the limit is the point rather than a defect.
Lapse and revival are different from expiry
| Lapse for non-payment | Term expiry | |
|---|---|---|
| Cause | A missed fee | The 20 years ran out |
| Revivable | Sometimes, by petition | Never |
| Basis | Delay was unintentional | — |
| Cost | Substantial petition fee | — |
| Intervening rights | May arise | — |
Revival is a remedy, not a plan. It is discretionary, it costs a substantial fee, and parties who began practising the invention during the lapse may retain some ability to continue.
Check the dates of any lapse, not just whether one occurred. What you did during that window may be protected.
Worked example: the misconception costing money
An owner assumes the patent can be extended later and defers deciding.
| Year | Belief | Reality |
|---|---|---|
| 11 | "We'll renew when it matters" | No renewal exists |
| 11.5 | Third fee due, $3,312 | Paid, to buy time |
| 14 | Considering a sale | 6 years left; buyers thin |
| 17 | Serious interest appears | 3 years left; declined |
| 20 | Term ends | Public domain, permanently |
| Fees paid | $3,312 at year 11.5 |
| Value realised | None |
| What would have worked | Selling at year 11, with 9 years remaining |
The deferral was based on a mechanism that does not exist. Believing more time could be bought later removed the urgency from a decision that had a real deadline.
Nine years of remaining term is saleable. Three is not.
Design and plant patents
| Utility | Design | Plant | |
|---|---|---|---|
| Term | 20 yrs from filing | 15 yrs from grant | 20 yrs from filing |
| Maintenance fees | Three | None | None |
| Anything to renew | No | Nothing at all | Nothing |
| Reaches full term | 41.4% | Almost always | Almost always |
Design patents require nothing after grant, which occasionally causes the opposite error — owners abandoning them in the belief a fee is due.
No fees means no attrition. See how long are design patents good for.
Improvement patents in practice
| Original patent | Improvement patent | |
|---|---|---|
| Expires | On its own schedule | 20 years from its own filing |
| Covers | The original invention | The improvement only |
| After the original expires | Public domain | Improvement still protected |
| Competitors may | Practise the original freely | Not the improvement |
This is the legitimate version of extending protection, and it protects something genuinely different.
It requires a real improvement that is itself novel and non-obvious over the original.
Foreign patents use the word "renewal"
| US | Most other jurisdictions | |
|---|---|---|
| Name | Maintenance fees | Renewal fees / annuities |
| Frequency | Three | Annual |
| Payable while pending | No | Often yes |
| Extends the term? | No | No |
The word differs; the mechanism does not. Annuities keep a patent alive within its term in every jurisdiction that charges them.
Nowhere lets you buy more term. See patent annuity fees by country.
What the data shows about ending early
| Ipiry Patent Survival Curve v1.0 | Rate |
|---|---|
| Survive the 3.5-year fee (2022 cohort) | 85.8% |
| Survive the 7.5-year fee (2018 cohort) | 64.6% |
| Reach full term (2014 cohort) | 41.4% |
| Abandoned before full term | 58.6% |
| Lost at the first fee | 14.2% |
| Lost at the second fee | 21.2 points |
| Lost at the third fee | 23.2 points |
| Conditional: paid first two, pay third | 63.0% |
Computed from 27,273,654 USPTO maintenance fee records covering 8,262,336 US utility patents — see the patent survival curve.
Most patents do not reach the term you cannot extend. Nearly three in five end at a fee window, by decision.
Which reframes the question. The realistic concern is not how to get more than twenty years; it is whether the patent earns its keep for the years it already has.
The grace period is not an extension
| Length | 6 months after each fee due date |
| Cost | Surcharge |
| Effect | Keeps the patent alive within its term |
| Extends the term | No |
| After it closes | Permanent expiry, no notice |
Using the grace period spends your safety margin. A good practice is paying before it, not during it, so an administrative failure still has room to be caught.
Nothing about the grace period changes the twenty-year end date.
Requests that do not work
| Request | Outcome |
|---|---|
| "Can I pay extra for more years?" | No mechanism exists |
| "Can I file a petition to extend?" | Only PTA and PTE, both time-limited |
| "The invention is still commercially important" | Irrelevant to term |
| "Nobody objected" | Irrelevant |
| "I did not know it was expiring" | Irrelevant |
There is no discretionary extension. Patent term is statutory and the offices have no authority to grant more.
What to do as expiry approaches
| Remaining term | Action |
|---|---|
| 10+ years | Full options — practise, license, sell, enforce |
| 5–7 years | Sell while buyers still want it |
| 3–4 years | Sale window closing fast |
| Under 3 years | Most buyers decline; license or practise |
| Final year | Prepare for the public domain |
Value falls sharply below roughly three years. A patent worth selling at year eight is frequently unsellable at year eleven.
Start any sale twelve months before a fee deadline, since the process takes months. See patent monetization.
Checking your own expiry date
| Step | Source |
|---|---|
| 1. Earliest non-provisional filing | Front page + Related U.S. Application Data |
| 2. Add Patent Term Adjustment | Front page |
| 3. Add any Patent Term Extension | USPTO records |
| 4. Apply any terminal disclaimer | Front page — caps it |
| 5. Confirm fees are current | USPTO Patent Center |
Step one catches most errors. A continuation runs from the earliest parent, not its own filing date.
Step five is the one that ends patents early. See patent status.
What outlasts a patent
| Protection | Duration |
|---|---|
| Trademark on the product name | Indefinite with renewal |
| Trade secret on undisclosed process detail | Indefinite while secret |
| Copyright in manuals and software | Long |
| Design patent on appearance | 15 yrs from grant |
| Brand, distribution, customer relationships | Not IP, but durable |
Trademarks genuinely renew indefinitely. That is the protection people are usually imagining when they ask about renewing a patent, and it is available on the name rather than the invention.
Trade secret has no expiry either, though filing a patent forecloses it permanently once the application publishes.
Worked example: the last three years
A patent with three years remaining, small entity, third fee due.
| Option | Cost | Outcome |
|---|---|---|
| Pay the third fee | $3,312 | Three more years of a right nobody is infringing |
| Sell | Broker commission | Most buyers decline at 3 years |
| License | — | No licensee identified |
| Release | $0 | Invention public 3 years early |
| File on a genuine improvement | Full filing cost | New 20-year term, improvement only |
| Also worth doing | Why |
|---|---|
| Register the product name | Trademark renews indefinitely |
| Keep process detail unpublished | Trade secret survives expiry |
| Check family members | One may have more term |
The improvement option is the only route to more protection, and it protects something different.
The trademark is what most owners actually want. Indefinite protection on the thing customers recognise, at a fraction of patent cost.
The one thing that does renew
| Patent | Trademark | |
|---|---|---|
| Renewable | No | Yes, indefinitely |
| Duration | 20 years, fixed | Unlimited with use and renewal |
| Protects | The invention | The name and brand |
| Cost per renewal period | — | Modest |
| Lost by | Expiry | Non-use, genericide |
Register the product name. It is cheaper than a patent, it renews forever, and it protects the thing customers actually recognise after the invention is public.
Many owners asking about patent renewal want this, and it is available.
Can you renew a patent: the checklist
- No. A patent cannot be renewed or extended beyond its term.
- Maintenance fees keep, they do not extend. Paying all three reaches twenty years, not beyond.
- PTA is calculated at grant, automatically, and cannot be requested later.
- PTE requires an application within sixty days of FDA approval.
- Refiling the same invention fails. Your own patent is prior art.
- Continuations add coverage, never term.
- Lapse may be revivable; term expiry never is.
- Design patents need nothing — no fees, no renewal, no decisions.
- Sell while term remains. Value falls sharply below three years.
- Register the trademark. That is the protection that genuinely renews forever.